Strides Shasun’s arm gets USFDA approval for Ibuprofen OTC Tablets

03 Jul 2018 Evaluate

Strides Shasun’s wholly owned subsidiary -- Strides Pharma Global has received final approval for Ibuprofen Tablets USP, 200 mg (OTC) from the United States Food & Drug Administration (USFDA). Ibuprofen Tablets 200 mg (OTC) is a generic version of Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer.

The product will be manufactured at the company’s Oral dosage facility at Puducherry and will be marketed by Strides Pharma in the US Market. The company has 75 cumulative ANDA filings with USFDA of which 51 ANDAs have been approved as of date and 24 are pending approval.

Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants. 

Strides Pharma Scien Share Price

808.95 12.75 (1.60%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×